- Home
- / Zomedica Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Zomedica Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.1
2024-10-29
Market Capitalization
$121 M
2024-10-29
Revenue
$32 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2022 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.1M | 18.9M | 25.2M | 27.3M | 32.0M | |||||
| Cost of goods sold | 1.1M | 5.3M | 7.9M | 8.2M | 10.4M | |||||
| Gross profit | 3.1M | 13.7M | 17.3M | 19.1M | 21.7M | |||||
| Gross profit margin, % | 72.1% | 70.0% | 67.7% | |||||||
| General and administrative expense | 2.9M | 3.9M | 4.5M | 7.1M | 6.0M | 22.7M | 33.0M | 29.0M | 29.7M | 24.5M |
| Operating expense total | 4.4M | 6.7M | 14.8M | 17.5M | 14.1M | 24.4M | 35.6M | 48.9M | 70.1M | 106.0M |
| Depreciation and amortization | 45.8K | 92.4K | 205.8K | 278.2K | 487.6K | |||||
| EBIT | (5.7M) | (8.1M) | 16.6M | (21.4M) | (21.9M) | (31.6M) | (51.1M) | (84.4M) | ||
| EBIT margin, % | -115.8% | -187.1% | -263.4% | |||||||
| Investment income | 5.5M | 4.0M | 2.4M | |||||||
| Interest expense | 18.3K | 732.0 | 6.1K | 1.0K | 175.0K | |||||
| Pre tax profit | (8.1M) | (16.6M) | (19.8M) | (16.9M) | (20.7M) | (19.4M) | (35.9M) | (47.5M) | (82.1M) | |
| Income tax expense | (2.3M) | (2.4M) | (1.3M) | (557.0K) | (278.0K) | |||||
| Net Income | (5.7M) | (8.1M) | (16.6M) | (18.4M) | (17.0M) | (34.5M) | (47.0M) | (81.9M) | ||
| EPS | 0.0 | (0.1) |